I'll have a go at arguing the positives. Agree there are obvious conflicts with software development , property rental and a management fee paid to entities associated with the 72 percent major shareholder and executive chairman ( doesn't read too good ok). These conflicts are however clearly disclosed and the Board looks reasonable.
Medtech Global as a software company is however more leveraged to success than some of these other companies associated with the Chairman i.e. In a a two horse race back the one called vested interest.
The Chair has been buying shares over the last few years .
Additionally manage my heath website appears to be the leading consumer portal in NZ now . The circa 50 percent owned Heath insurance verification business Consova in the US looks to be getting traction on the back of Obama Heath insurance changes .
So in summary Medtech has always had conflicts but the underlying business feels like it's improving. Maybe play the ball not the man?
MDG Price at posting:
8.1¢ Sentiment: ST Buy Disclosure: Held